1.Changes of Splenocyte Proliferative Capacity and Subpopulation of Peripheral Lymphocytes Related to the Hemorrhage Amount in Rats.
Hahn Shick LEE ; Sung Pil CHUNG ; Uk Jin KIM ; Young Soon CHO ; Seok Joon JANG
Journal of the Korean Society of Emergency Medicine 2000;11(3):269-275
BACKGROUND: Hemorrhage itself has been shown to produce abnormalities in immunity, particularly depression of the lymphocyte function. In order to better examine the amount of hemorrhage required to suppress the lymphocyte function, we determined the effect of graded fixed-volume hemorrhage on splenocyte proliferation and the lymphocyte subpopulation. METHODS: Male Sprague-Dawley rats(weight, 350~400g) were anesthetized, subjected to hemorrhages of 7.5ml/kg, 15ml/kg, and 22.5ml/kg by percutaneous cardiac puncture with 26G needles. After 1, 2, 4, and 7 days, animals were killed to obtain the blood and spleen. The splenocyte proliferative capacity was measured by using the tritiated thymidine incorporation technique, and the peripheral lymphocyte subpopulation was determined using flow cytometry with the following monoclonal antibodies: T cell(CD3+), T helper cell(CD4+), T cytotoxic cell(CD8+), and B cell(CD45RA+). RESULTS: Hemorrhage of 7.5ml/kg did not induce depression of splenocyte proliferation. However, for hemorrhage greater than 15ml/kg, the splenocyte proliferative capacity was significantly depressed at 2 days after hemorrhage and recovered at 4 days. Hemorrhage induced no changes in the relative percentage of lymphocyte subpopulations and in the number of each cell in peripheral blood. CONCLUSION: This study suggests that cellular immunity is depressed at 48 hrs after a hemorrhage greater than 15ml/kg without any change in the peripheral lymphocyte subpopulation.
Animals
;
Antibodies, Monoclonal
;
Depression
;
Flow Cytometry
;
Hemorrhage*
;
Humans
;
Immunity, Cellular
;
Lymphocyte Subsets
;
Lymphocytes*
;
Male
;
Needles
;
Punctures
;
Rats*
;
Rats, Sprague-Dawley
;
Spleen
;
Thymidine
2.A Case of Malignant Melanoma in Children.
Joong Hyun BIN ; Pil Sang JANG ; Soh Yeon KIM ; Nak Gyun CHUNG ; Bin CHO ; Soon Ju LEE ; In Goo LEE ; Hack Ki KIM
Korean Journal of Pediatric Hematology-Oncology 2001;8(2):378-381
Malignant melanoma is a very rare disease in children. There is an increased risk for the development of malignant melanoma in patient with giant congenital melanocytic nevus. The manifestations of distant metastases in malignant melanoma commonly indicate a poor prognosis. First line treatment of malignant melanoma is excision, but when associated with giant congenital melanocytic nevus, excision is very difficult due to the site and the size of the lesions. However, malignant melanoma is not sensitive to chemotherapy, but a child is more sensitive than an adult. We report a case of unresectable childhood malignant melanoma associated with a giant congenital melanocytic nevus in a 3 year-old female treated with chemotherapy.
Adult
;
Child*
;
Child, Preschool
;
Drug Therapy
;
Female
;
Humans
;
Melanoma*
;
Neoplasm Metastasis
;
Nevus, Pigmented
;
Prognosis
;
Rare Diseases
3.Mature Teratoma of the Gastrohepatic Ligament.
Ji Hoon KIM ; Hyuk Jai JANG ; Yong Ho KIM ; Yong Pil CHO ; Seung Mun JUNG ; Yang Soon PARK ; Myeng Sik HAN
Journal of the Korean Surgical Society 2003;65(5):474-477
Teratomas are tumors composed of derivatives of all three germinal cell layers. They have been described in a variety of organs in both children and adults, most commonly in the gonads. Extragonadal intraperitoneal teratomas are very rare. We here report a case of a large mature teratoma of the gastrohepatic ligament in a 20-year-old woman. To the best of our knowledge, a teratoma of the gastrohepatic ligament has never before been described, although there are a few reports of teratomas arising from the greater and lesser omentum.
Adult
;
Child
;
Female
;
Gonads
;
Humans
;
Ligaments*
;
Omentum
;
Teratoma*
;
Young Adult
4.A Nasal Myiasis in a 76-Year-Old Female in Korea.
Jae Soo KIM ; Pil Won SEO ; Jong Wan KIM ; Jai Hyang GO ; Soon Cheol JANG ; Hye Jung LEE ; Min SEO
The Korean Journal of Parasitology 2009;47(4):405-407
On July 2009, 5 fly larvae were discovered inside the nose of a 76-year-old female. She was living in Cheonan-si, and in a state of coma due to rupture of an aortic aneurysm. Surgery was performed on the day of admission, and the larvae were found 4 days later. By observing their posterior spiracle, the larvae were identified as Lucilia sericata. Considering the rapid development of this species, the infection was likely acquired during hospitalization. Further investigation on the hospital environment should be needed to know the origin of the infection.
Aged
;
Animals
;
Aortic Rupture/complications
;
Cross Infection/diagnosis/parasitology
;
*Diptera
;
Female
;
Humans
;
Korea
;
*Larva
;
Myiasis/*diagnosis/*parasitology
;
Nose Diseases/*diagnosis/*parasitology
5.The association of serum CA-125 level and severity of dysmenorrhea with lesion depth in adenomyosis.
Seog Hyun JANG ; Tae Soon ANN ; En Sung OH ; Jae Hag SIM ; Ae Lan PAIK ; Jong Cheon WEON ; Kang Woo JUNG ; Yong Pil KIM
Korean Journal of Obstetrics and Gynecology 2004;47(12):2380-2383
OBJECTIVE: To evaluate the association of level of CA-125 and severity of dysmenorrhea with lesion depth in adenomyosis. METHODS: Sixty-eight women who had undergone hysterectomy and were found to have pure adenomyosis on histopathologic examination were reviewed retrospectively. Specimens were stratified according to the degree of adenomyosis penetration into 4 groups: group A consisted of specimens with adenomyosis penetration into myometrium of up to 25%; group B, 26-50%; group C, 51-75%, and group D, >75%. All women were submitted to serum determination of CA-125. Severity of dysmenorrhea was assessed by means of a modification of 10-point verbal rating scale. RESULTS: Each group was not correlated with severity of dysmenorrhea (p=0.7394 Fisher's exact test). The means of serum CA-125 levels was increased corresponding to depth of adenomyosis (p=0.0441 ANOVA test). CONCLUSION: In this study, serum CA-125 level is associated with the depth lesion and severity of dysmenorrhea is not. Therefore, the level of serum CA-125 might be useful indicator in management of adenomyosis before surgery.
Adenomyosis*
;
Animals
;
Dysmenorrhea*
;
Female
;
Humans
;
Hysterectomy
;
Mice
;
Myometrium
;
Retrospective Studies
6.Complications of Sturmdorf's suture in cold knife conization.
Tae Soon AN ; Seog Hyun JANG ; Eun Sung OH ; Jae Hag SIM ; Kang Woo JUNG ; Jong Cheon WEON ; Yong Pil KIM
Korean Journal of Obstetrics and Gynecology 2004;47(10):1899-1904
OBJECTIVE: It has been recognized that cold knife conization has higher incidence of postoperative hemorrhage and many techniques have been developed in an attempt to control hemorrhage. The aim of this study was to evaluate complications of Sturmdorf's suture in cold knife conization and to investigate various measures employed to reduce blood loss. METHODS: The results of 85 patients who had cold knife conization for diagnosis or treatment of cervical intraepithelial neoplasia (CIN) from August, 1997 to July, 2003 were reviewed. RESULTS: Among 85 patients, 83 patients (97.7%) had negative cut margins on conization specimen while 2 patients (2.3%) positive cut margins. 54 patients received no further treatment after cold knife conization and complications occurred in 9 patients (16.7%). Postoperative hemorrhage requiring additional hemostatic procedures occurred in 7 patients (13%), of which 6 patients were rehospitalized and 1 patient was managed at outpatient clinic with gauze packing only. Among 6 rehospitalized patients, hysterectomy was done in 2 patients and electrocoagulation in 1 patient. Packed red cell was transfused in 1 patient and 2 patients were managed with gauze packing only. Postoperative infection was found in 2 patients (3.7%). No other significant complications were noted. CONCLUSION: Cold knife conization using Sturmdorf's suture could be done to get much more accurate results of biopsy with relatively mild complication in magement of CIN, although several days? admission is needed and the other alternative methods seem to be more convenient.
Ambulatory Care Facilities
;
Biopsy
;
Cervical Intraepithelial Neoplasia
;
Conization*
;
Diagnosis
;
Electrocoagulation
;
Hemorrhage
;
Humans
;
Hysterectomy
;
Incidence
;
Postoperative Hemorrhage
;
Sutures*
7.Segmental Ischemia of the Small Bowel Caused by Cytomegalovirus Infection in a Patient with Multiple Injuries after a Traffic Accident.
Kil Chun PARK ; Hyuk Jai JANG ; Yong Pil CHO ; Yong Ho KIM ; Seung Mun JUNG ; Yang Soon PARK ; Myeng Sik HAN
Journal of the Korean Surgical Society 2004;66(5):430-434
Cytomegalovirus infections (CMV) of the gastrointestinal tract (GI) are common, and most often seen in patients with acquired immunodeficiency syndrome (AIDS), inflammatory bowel disease, or those receiving immunosuppressive therapy. CMV enteritis is uncommon in an immunocompetent individual. A CMV infection of the small bowel accounts for 4.3% of all CMV infections of the GI tract. The GI manifestations of CMV include: diarrhea, bleeding, obstruction and perforation, all of which are usually secondary to discrete erosions or ulceration. High mortality rates have been reported for CMV enteritis. Here, a rare case of CMV enteritis, resulting in segmental ileal ischemia, is reported in a 47-year old man following a traffic accident. On the 17th hospital day, he developed melena, watery diarrhea, fever and abdominal pain. An abdominal computed tomography (CT) on the 23rd hospital day showed an enlarged appendix with mild periappendiceal infiltration and segmental wall thickening in the terminal ileum. An ileocecal resection was performed. Pathological evaluation of the operative specimen revealed CMV inclusion bodies, with ulcerations. The patient was treated with ganciclovir therapy for 3 weeks after which his symptoms improved. If a CMV infection is highly suspected in multiply injured trauma victims, the earlier recognition of potential small bowel involvement can hopefully decrease the incidence of bleeding, ischemic demage to the bowel and perforation, which are usually fatal events.
Abdominal Pain
;
Accidents, Traffic*
;
Acquired Immunodeficiency Syndrome
;
Appendix
;
Cytomegalovirus Infections*
;
Cytomegalovirus*
;
Diarrhea
;
Enteritis
;
Fever
;
Ganciclovir
;
Gastrointestinal Tract
;
Hemorrhage
;
Humans
;
Ileum
;
Incidence
;
Inclusion Bodies
;
Inflammatory Bowel Diseases
;
Ischemia*
;
Melena
;
Middle Aged
;
Mortality
;
Multiple Trauma*
;
Ulcer
8.Survival Rates and Prognostic Factors in Childhood Medulloblastoma and Supratentorial Primitive Neuroectodermal Tumor.
Pil Sang JANG ; Keon Hee YOO ; Dong Soon LEE ; Chong Jai KIM ; Hee Young SHIN ; Kyu Chang WANG ; Il Han KIM ; In One KIM ; Hyo Seop AHN
Korean Journal of Pediatric Hematology-Oncology 2000;7(2):249-255
PURPOSE: Children under 3 years old with medulloblastoma (MB) or supratentorial primitive neuroectodermal tumor (SPNET) have a poor prognosis. They are more susceptible to the deleterious effects of craniospinal radiation (CSR). This study was undertaken to determine the survival rates and prognostic factors of currently used treatment. METHPDS: Retrospective review of 19 children (MB 16, SPNET 3) who were newly diagnosed as MB or SPNET at Seoul National University Children's Hospital from April 1996 to August 2000 was done. Eligible Patients were treated with postoperative induction chemotherapy using Children's Cancer Group (CCG) 9921A or 9931. Patients over 3 year of age received CSR as well. RESULTS: Three Patients with SPNET are all alive without disease. However, 6 patients under 3 years old at diagnosis with MB were all dead whereas only one patient had an event among 10 patients over 3 years old at diagnosis. Among patients with MB, age under 3 years at diagnosis or residual tumors after induction chemotherapy correlated with poor outcome. Metastasis at diagnosis, postoperative residual disease or extent of excision did not have a significant effect on survival statistically. Three-year event-free survival (EFS) of patients with MB was 53%. Three-year EFS of patients over 3 years old at diagnosis with MB was 85.7% and 1-year EFS of under 3 years old at diagnosis with MB was 16.7%. CONCLUSION: The combined use of chemotherapy and CSR in the treatment of MB and SPNET improved survival in children over 3 years old, whereas any treatment failed to improve survival in children under 3 years old. So, there's a need for a new treatment modality to improve survival of children under 3 year of age.
Child
;
Child, Preschool
;
Diagnosis
;
Disease-Free Survival
;
Drug Therapy
;
Humans
;
Induction Chemotherapy
;
Medulloblastoma*
;
Neoplasm Metastasis
;
Neoplasm, Residual
;
Neuroectodermal Tumors, Primitive*
;
Prognosis
;
Retrospective Studies
;
Seoul
;
Survival Rate*
9.Complete Remission by Imatinib Mesylate (Glivec) in a Child Relapsing with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph (+) ALL) after Unrelated Donor Stem Cell Transplantation.
Young Yeui KIM ; Young Kyoung YOO ; Sun Young KIM ; Pil Sang JANG ; Nak Gyun CHUNG ; Bin CHO ; Dae Chul JEONG ; Soon Ju LEE ; Hack Ki KIM
Korean Journal of Pediatric Hematology-Oncology 2003;10(1):110-114
The prognosis of patients with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph ALL) who relapsed after allogeneic stem cell transplantation (allo-SCT) is poor. Imatinib mesylate (Glivec (R) ) is an inhibitor of the ABL tyrosine kinase with potent antileukemic activity in advanced Ph ALL. The clinical effects of imatinib on Ph ALL recurring after allo-SCT have not been established. We describe the clinical activity of imatinib in a 7 year-old boy with Ph ALL relapsing after unrelated donor stem cell transplantation. Imatinib as a single agent resulted in rapid elimination of leukemic cells with ensuing prolonged neutropenia and thrombocytopenia. Subsequent hematological recovery by donor-derived cells was associated with grade 3 graft-versus-host disease (GvHD), which responded to cyclosporine A and steroid. Imatinib successfully induced hematologic, cytogenetic and molecular remission of Ph ALL, and restored complete donor chimerism, along with controllable GvHD.
Child*
;
Chimerism
;
Cyclosporine
;
Cytogenetics
;
Graft vs Host Disease
;
Humans
;
Hydrogen-Ion Concentration
;
Male
;
Mesylates*
;
Neutropenia
;
Philadelphia Chromosome*
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
;
Prognosis
;
Protein-Tyrosine Kinases
;
Stem Cell Transplantation*
;
Stem Cells*
;
Thrombocytopenia
;
Tissue Donors
;
Unrelated Donors*
;
Imatinib Mesylate
10.The Effects of Multiple Transfusion on the Outcomes of Bone Marrow Transplantation from HLA-matched Sibling Donor in Patients with Severe Aplastic Anemia.
Joong Hyun BIN ; Young Kyoung YOO ; Sun Young KIM ; Pil Sang JANG ; Nak Gyun CHUNG ; Bin CHO ; Dae Chul JEONG ; Soon Ju LEE ; Hack Ki KIM
Korean Journal of Pediatric Hematology-Oncology 2003;10(1):30-38
PURPOSE: We investigated the effects of pretransplant-transfusion on engraftment, graft versus host disease (GVHD) and graft rejection after bone marrow transplantation (BMT) in children with severe aplastic anemia who had HLA-identical sibling donor. METHODS: We reviewed retrospectively the medical records of 47 children with severe aplastic anemia who received grafts from HLA-matched sibling donor using same conditioning regimen (procarbazine, antithymocyte globulin, and cyclophosphamide) from September 1986 to May 2001. GVHD prophylaxis consisted of cyclosporine and short-term methotrexate. Patients receiving multiple transfusion more than 40 transfused units in total before BMT were defined as high-risk group (HRG) and those with less than 40 transfused units were as standard-risk group (SRG). RESULTS: Among 47 patients, 30 patients were classified into SRG and remaining 17 were into HRG. The median time from diagnosis to transplant was 4 (range, 1~14) months in SRG and 36 (range, 3~360) months in HRG. Primary engraftment was achieved in all patients. Acute GVHD (> or =grade II) in HRG (13.3%) was comparable with in SRG (5.9%) (P=0.221), meanwhile corresponding fugures for chronic GVHD was 1 (3.3%) and 2 (11.8%). All of these patients have experienced complete resolution of GVHD and are no longer receiving immunosuppressive therapy. Booster stem cell infusion was needed for poor graft function (n=3) in SRG and also for poor graft function (n=1) or progressive rejection (n=3) in HRG. Five-year disease free survival rate was 100% in SRG and 94.1 6% in HRG (P=0.18). CONCLUSION: These findings suggest that multiple transfusion may be not a risk factor for rejection or poor outcome. Progressive rejection was observed only in patients with multiple transfusion but did not affect the survival.
Anemia, Aplastic*
;
Antilymphocyte Serum
;
Bone Marrow Transplantation*
;
Bone Marrow*
;
Child
;
Cyclosporine
;
Diagnosis
;
Disease-Free Survival
;
Graft Rejection
;
Graft vs Host Disease
;
Humans
;
Medical Records
;
Methotrexate
;
Retrospective Studies
;
Risk Factors
;
Siblings*
;
Stem Cells
;
Tissue Donors*
;
Transplants